Connect with us

Health

Experts Battle to Quell Ebola Outbreak in DR Congo

Published

on

By Dipo Olowookere

The United Nations (UN) World Health Organization (WHO) said on Friday that a race against the clock has begun to contain an outbreak of Ebola in a remote northern area of the Democratic Republic of the Congo (DRC).

On 9 May, WHO said it noticed a cluster of unexplained illnesses and death, all with bleeding symptoms in the same area.

WHO, the Congolese Government and the medical aid organization, Alima, immediately deployed a team to the field and lab tests confirmed it was Ebola. Two days later, the DRC Ministry of Health officially declared an outbreak of the virus.

It was gathered that about 20 cases of Ebola have been reported in the DRC’s Bas Uele Province – near the vast country’s border with the Central African Republic – two have been confirmed by laboratory tests and three people have died so far, the agency says.

“It’s important to note that Likati Health Zone is one of the most remote parts of the DRC. It is 1400 kilometres from Kinshasa and 350 kilometres from the nearest major town, Kisangani,” said Dr. Peter Salama, the WHO Executive Director for Health and Emergencies Programmes, speaking to the press in Geneva.

He also said there are only 20 kilometres of paved roads in that area and virtually no functional telecommunications. It is also an area that has been subject to insecurity and displacement. “The Lord’s Resistance Army is believed to be active in the area and their displaced populations from the ongoing conflict in the Central African Republic,” he noted.

With the help of the UN, the first search teams, led by the DRC’s Ministry of Health, flew into Likati on yesterday. Their immediate priority is to follow the 400 plus contacts of the suspected Ebola cases.

The focus is on surveillance, getting the best information on the suspected cases, diagnosing people who have come in contact with an infected person, case management, isolating those who are infected to prevent the spread of the disease and more importantly engaging with the community, explained Dr. Salama.

Meanwhile, the first Ebola treatment centre has been established in the Likati General Hospital. Protective gear has been dispatched to health workers and a mobile lab is being constructed and then deployed to the area. Immediate repairs to air strips and telecommunications are also being carried out.

The first six months of the operation are expected to cost $10 million.

Risk assessment ‘high’ at national level; ‘low risk’ globally

WHO has determined overall that the risk assessment for this event is “high” at the national level, medium at the regional level and low at the global level.

An experimental vaccine for Ebola is being tested in Guinea, where the first outbreak of Ebola in West Africa was reported.

The trials there have been “promising” and the vaccines has proven to be efficient and safe so far, Dr. Salama told reporters, while Dr. Matshidiso Moeti, WHO Regional Director for Africa, added that she is encouraged by the rapid response to quell the outbreak.

“We have not received an official request from the Government for this vaccine but they have been made aware that this possibility exists both to benefit from this new tool and also to add their support in the testing of this vaccine, she said, reiterating the experimental nature of the vaccine and expressed hope the authorities “will work with us to consider this and make a decision.”

This is the eighth outbreak in the DRC since 1976. The most recent was in 2014, around the time more than 11,000 people died and some 28,000 cases were reported in the Ebola outbreak in West Africa, mainly in Guinea, Sierra Leone and Liberia.

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

Health

SUNU Health Named Most Customer Focused HMO of the Year

Published

on

SUNU Health --logo

By Modupe Gbadeyanka

The decision of the management of SUNU Health Nigeria Limited to adopt the strategy of placing the enrollee and customer at the heart of its operations has started to pay off.

The company was recently announced as Most Customer-Focused Health Insurance Company of the Year at the Customer Service Standard Magazine Awards 2025.

The recognition underscored the company’s success in translating its dedication into tangible enrollee satisfaction and superior market service at the Nigerian Health Maintenance Organisation (HMO) landscape.

It also highlights the organisation’s dedicated efforts in streamlining claims processing, enhancing access to quality healthcare providers, and maintaining transparent, responsive communication channels with its diverse client base across Nigeria.

The accolade further serves as a powerful testament to the successful integration of digital solutions and human-centric service models at SUNU Health.

It positions the firm as a leader not only in providing robust health plans but also in delivering the supportive, personalized care that enrollees truly value.

“Clinching the Most Customer-Focused Health Insurance Company of the Year award is not just an honour; it is a validation of the core philosophy that drives every member of the SUNU Health team.

“We believe that healthcare is fundamentally a service industry, and our success is measured by the well-being and satisfaction of our enrollees,” the chief executive of SUNU Health, Mr Patrick Korie, commented.

“This award reinforces our resolve to continuously innovate and set new benchmarks for customer experience in the Nigerian health insurance sector.

“Our commitment to providing accessible, high-quality, and seamless healthcare solutions remains our top priority as we move into the new year (2026),” he added.

Continue Reading

Health

Nigeria Launches First National Antimicrobial Resistance Survey

Published

on

Antimicrobial Resistance Survey

By Adedapo Adesanya

Nigeria has launched its first nationally representative survey on antimicrobial resistance to generate critical data to guide evidence-based policies, improve patient outcomes, and strengthen health system resilience.

Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites evolve to resist treatment, making infections harder to cure.

As a result, surveillance is essential to track resistance patterns, identify priority pathogens, and guide targeted interventions and with support from the World Health Organization (WHO) and other partners, the initiative marks a milestone in the country’s public health response.

Nigeria becomes the third country globally to partner with WHO on a national antimicrobial resistance survey. having been selected based on the country’s strong commitment to AMR surveillance, its updated WHO Nigeria NAP 2.0, and readiness to expand laboratory and data systems.

Africa’s most populous country ranks 20th globally for age-standardized mortality due to antimicrobial resistance . In 2019, an estimated 263,400 deaths in Nigeria were linked to  it—more than the combined deaths from enteric infections, tuberculosis, respiratory infections, maternal and neonatal disorders, neglected tropical diseases, malaria, and cardiovascular diseases.

Globally, resistant infections in tertiary care settings cost between $2,371 and $29,289 per patient episode, extend hospital stays by an average of 7.4 days, and increase mortality risk by 84 per cent.

The survey will see the establishment of a national baseline on antimicrobial resistance prevalence to monitor interventions, assess the distribution, burden (morbidity, mortality, DALYs, cost), and diversity of AMR across regions and populations, as well as contribute to the global target of reducing AMR deaths by 10 per cent by 2030, in line with the political declaration endorsed at the 79th United Nations General Assembly in 2024.

It also seeks to strengthen routine antimicrobial resistance surveillance, including diagnostics, sample referral systems, and laboratory capacity.

Using WHO’s standardized methodology, the survey will run for 12–15 months and cover 40–45 randomly selected health facilities nationwide. Patients with suspected bloodstream infections (BSIs) will be identified using standard case definitions, and blood samples will be analysed in quality-assured laboratories.

Data will be collected across all age groups, covering clinical, demographic, laboratory, financial, and outcome indicators. Follow-up will occur at discharge, 28 days, and three months post-infection. The survey will sample approximately 35,000 patients suspected of BSIs to obtain around 800 isolates of the most common pathogens.

Dr Tochi Okwor, Acting Head, Disease Prevention and Health Promotion, Nigeria Centre for Disease Control and Prevention (NCDC) said, “With WHO’s support, we are confident the survey will generate the evidence needed to protect public health.”

WHO Representative in Nigeria, Dr Pavel Ursu, reaffirmed WHO’s commitment stating that ,“Nigeria is taking a decisive step toward combating AMR with an approach grounded in data, science, and measurable impact. This survey will provide the clarity needed to drive smarter policies, stronger surveillance, and better patient outcomes. Nigeria is laying the foundations for a resilient health system, one that protects lives, strengthens trust, and ensures that essential medicines remain effective for future generations.”

Adding her input, Dr Laetitia Gahimbare, Technical Officer at WHO Regional Office for Africa, added:“Strengthening surveillance enhances Nigeria’s capacity to detect and respond to AMR threats, supporting better patient outcomes, reinforcing health security, and building a resilient system.”

Professor Babatunde Ogunbosi, Paediatric Infectious Diseases Specialist at University College Hospital, Ibadan, highlighted the broader impact:, “This survey is about more than data. It’s about building national capacity for research, diagnostics, and policy. It integrates science into public health decision-making.”

Continue Reading

Health

Our Vision Extends Beyond Offering Health Insurance Packages—SUNU Health

Published

on

SUNU Health walk

By Modupe Gbadeyanka

One of the leading Health Maintenance Organisations (HMOs) in Nigeria, SUNU Health, has said its philosophy is proactive wellness, noting that this was why it recently partnered with The Divine Physician and St. Luke Catholic Chaplaincy Centre for a community health initiative.

The chief executive of the company, Dr Patrick Korie, said, “SUNU Health’s vision extends far beyond merely offering health packages and insurance.”

“We are fundamentally interested in proactive wellness—preventing illness rather than just treating it. This annual exercise is a crucial part of that commitment, and we will continue to champion it for as long as we exist,” he stressed.

The medical practitioner led the company’s annual Health Walk in Lagos on Saturday, November 8, 2025. The event drew hundreds of health enthusiasts, including the Chaplain of the centre, Rev Fr. John Okoria SJ.

His active participation reinforced the spiritual and moral commitment to holistic well-being, proving crucial in mobilizing staff and community members, thereby ensuring the vital wellness message reached a broad and deeply engaged audience.

The health walk covered several major streets in Lagos, starting from Ishaga Road and navigating through Itire Road, Randle Avenue, Akerele, Ogunlana Drive, and Workers Street before concluding back at the starting point. Following the vigorous walk, participants engaged in a session of high-energy aerobics and other outdoor exercises, reinforcing the day’s focus on fitness.

“We are delighted to champion this vital health initiative alongside the Catholic Chaplaincy Centre LUTH/CMUL. The turnout was truly delightful, reflecting the community’s deep desire to embrace wellness.

“Collaborations like this amplify our message and commitment to the Nigerian community,” the Brand and Corporate Communications Lead at SUNU Health, Mr Samuel Olayemi, stated.

Continue Reading

Trending